Volume Stonkers | Intra-Cellular surged 34.07%, Johnson & Johnson plans largest biotech acquisition in two years

Generated by AI AgentStock Spotlight
Monday, Jan 13, 2025 4:31 pm ET2min read
BTC--
MS--
NVDA--
TSLA--
NVIDIA, ranked first in trading volume, fell 1.97% with a trading volume of $26.618 billion. NVIDIA criticized the Biden administration's chip quota proposal as "overreaching" and announced a breakthrough in physical AI.

Tesla, ranked second, rose 2.17% with a trading volume of $25.232 billion. Tesla announced the implantation of its brain-machine interface chip in a third test subject and received an optimistic valuation from Morgan Stanley, which raised its price target.

Apple, in third place, dropped 1.03% with a trading volume of $11.481 billion. Apple is facing a £1.5 billion legal claim in the UK, and its global market share is under threat.

Microsoft, ranked fourth, fell 0.42% with a trading volume of $7.203 billion. Microsoft expanded its partnership with HCLTech to revolutionize call centers using generative AI and formed a new AI team.

Meta, in fifth place, declined 1.22% with a trading volume of $6.458 billion. Meta is under pressure from a looming TikTok ban, and its target price was raised by YAYUN shares.

Amazon, ranked sixth, decreased 0.22% with a trading volume of $5.896 billion. Amazon's diversity strategy differs from other tech giants, and it participated in NRG Energy's stock transaction.

Broadcom, in seventh place, rose 0.44% with a trading volume of $5.198 billion. Broadcom entered a new $7.5 billion revolving credit facility, terminating its 2021 credit agreement.

MicroStrategy, ranked eighth, increased 0.15% with a trading volume of $4.946 billion. MicroStrategy resumed Bitcoin purchases, acquiring approximately 2,530 Bitcoins.

Intra-Cellular, in ninth place, surged 34.07% with a trading volume of $4.563 billion. Johnson & Johnson plans to acquire Intra-Cellular for billions, marking the largest biotech acquisition in nearly two years.

Advanced Micro Devices (AMD), ranked tenth, rose 1.10% with a trading volume of $4.477 billion. Goldman Sachs maintained a hold rating on AMD, noting that laptop shipments exceeded expectations.

Palantir, in eleventh place, dropped 3.39% with a trading volume of $4.367 billion. Palantir underperformed last week, was reduced by ARK, and market sentiment remains pessimistic.

Alphabet A, ranked twelfth, fell 0.54% with a trading volume of $4.113 billion. Google Cloud formed a new AI sales team and conducted layoffs to improve project efficiency.

UnitedHealth, in thirteenth place, rose 4.00% with a trading volume of $3.406 billion. Morgan Stanley maintained a buy rating on UnitedHealth and raised its price target.

TSMC, ranked fourteenth, dropped 3.31% with a trading volume of $3.254 billion. The White House's decision to restrict AI chip exports affected TSMC's stock price, raising market concerns about AI chip export restrictions.

Visa, in fifteenth place, decreased 0.29% with a trading volume of $2.880 billion. Visa's target price was raised by AllianceBernstein, and it offers merchant refund application services.

Eli Lilly, ranked sixteenth, fell 0.26% with a trading volume of $2.872 billion. Eli Lilly plans to acquire Scorpion and expects its weight-loss drug to be approved in early 2026.

Alphabet C, in seventeenth place, declined 0.46% with a trading volume of $2.511 billion. Google announced the transfer of the AI Studio team to DeepMind to enhance efficiency.

Netflix, ranked eighteenth, rose 0.31% with a trading volume of $2.476 billion. Macquarie maintained an outperform rating on Netflix, with analysts optimistic about its long-term dominance in the streaming sector.

JPMorgan Chase, in nineteenth place, increased 1.81% with a trading volume of $2.421 billion. JPMorgan Chase provided disaster forbearance support to mortgage clients affected by the Los Angeles wildfires.

Micron Technology, ranked twentieth, fell 4.31% with a trading volume of $2.134 billion. Micron was affected by the White House's AI chip export restrictions, but UBS maintained its buy rating.

Fantastic stocks and where to find them

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet